- To prevent cachexia (muscle wasting) in advanced cancer and AIDS
Small studies show that a combination of glutamine, arginine, and beta-hydroxy-beta-methylbutyrate (Juven®) can promote weight gain in these patients, but the long-term effectiveness is not known.
- To prevent mucositis caused by cancer-related treatments
Several studies suggest that oral glutamine supplementation may be helpful as supportive care for inflammation of oral mucous membranes caused by cancer treatments. Larger confirmatory trials are needed.
- To reduce chemotherapy-induced gastrointestinal toxicity
One study showed that glutamine given intravenously to patients receiving chemotherapy for gastric or colorectal cancer significantly reduced nausea, vomiting, and diarrhea.
- To treat chemotherapy-related neuropathy
Preliminary studies suggest that glutamine may help treat neuropathy caused by chemotherapy. But larger trials are needed.
- To improve tissue integrity
Clinical research supports the use of intravenous glutamine to enhance the integrity of intestines in critically ill patients.
- To stimulate the immune system
Although glutamine is a necessary fuel source for lymphocytes, a type of immune cell, there is no solid evidence that glutamine supplements can stimulate the immune system in healthy people. In some studies, intravenous glutamine helped improve immune status, prevent infection, and prevent depletion of intestinal immune cells in critically ill patients and those recovering from surgery.
- Intravenously, to improve recovery from surgery
Several clinical trials support this use.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.